Escherichia coli edible vaccine - ProdiGeneAlternative Names: ETEC edible vaccine - ProdiGene; Lt-B vaccine
Latest Information Update: 24 Apr 2007
At a glance
- Originator ProdiGene
- Class Escherichia coli vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Escherichia coli infections
Most Recent Events
- 16 Aug 2002 Phase-I clinical trials in Escherichia coli infections in USA (PO)